Giuseppe Di

3.1k total citations · 1 hit paper
22 papers, 2.1k citations indexed

About

Giuseppe Di is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Giuseppe Di has authored 22 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 15 papers in Immunology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Giuseppe Di's work include Cancer Immunotherapy and Biomarkers (12 papers), Immune Cell Function and Interaction (8 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Giuseppe Di is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Immune Cell Function and Interaction (8 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Giuseppe Di collaborates with scholars based in Italy, United States and Switzerland. Giuseppe Di's co-authors include Fabio Grizzi, Federica Marchesi, Luigi Laghi, Alberto Mantovani, Paola Allavena, Paolo Bianchi, Alberto Malesci, Michael Karin, Zhenyu Zhong and Elsa Sánchez‐López and has published in prestigious journals such as Nature, Immunity and Gastroenterology.

In The Last Decade

Giuseppe Di

21 papers receiving 2.0k citations

Hit Papers

Immunosuppressive plasma cells impede T-cell-dependent im... 2015 2026 2018 2022 2015 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giuseppe Di Italy 16 1.3k 1.2k 469 259 207 22 2.1k
Lucas Ferrari de Andrade United States 16 1.6k 1.2× 1.6k 1.3× 666 1.4× 217 0.8× 328 1.6× 29 2.6k
Jing-Jing Zhao China 25 813 0.6× 786 0.6× 448 1.0× 244 0.9× 154 0.7× 37 1.5k
Sijin Cheng China 15 732 0.6× 736 0.6× 660 1.4× 363 1.4× 209 1.0× 29 1.7k
Shuang‐Jian Qiu China 22 1.9k 1.5× 1.9k 1.6× 607 1.3× 457 1.8× 341 1.6× 35 3.2k
Yagai Yang United States 8 1.2k 0.9× 1.1k 0.9× 384 0.8× 88 0.3× 152 0.7× 11 1.7k
Vladimir Kravtsov Israel 12 852 0.6× 1.0k 0.9× 604 1.3× 226 0.9× 294 1.4× 35 1.9k
Jonathan B. Mitchem United States 18 1.8k 1.4× 1.5k 1.2× 578 1.2× 332 1.3× 209 1.0× 46 2.6k
Yong Yi China 27 905 0.7× 663 0.5× 607 1.3× 474 1.8× 236 1.1× 68 2.0k
Yuping Sun China 27 1.3k 1.0× 831 0.7× 818 1.7× 413 1.6× 502 2.4× 87 2.4k
Hongyong He China 22 784 0.6× 685 0.6× 546 1.2× 262 1.0× 490 2.4× 63 1.7k

Countries citing papers authored by Giuseppe Di

Since Specialization
Citations

This map shows the geographic impact of Giuseppe Di's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Di with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Di more than expected).

Fields of papers citing papers by Giuseppe Di

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Di. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Di. The network helps show where Giuseppe Di may publish in the future.

Co-authorship network of co-authors of Giuseppe Di

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Di. A scholar is included among the top collaborators of Giuseppe Di based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Di. Giuseppe Di is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Todoric, Jelena, Laura Antonucci, Giuseppe Di, et al.. (2017). Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas. Cancer Cell. 32(6). 824–839.e8. 109 indexed citations
3.
Malesci, Alberto, Paolo Bianchi, Giuseppe Celesti, et al.. (2017). Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer. OncoImmunology. 6(12). e1342918–e1342918. 100 indexed citations
4.
Di, Giuseppe, Michele Carvello, Samantha Pesce, et al.. (2016). Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer. PLoS ONE. 11(2). e0148186–e0148186. 31 indexed citations
5.
Einwallner, Elisa, Florian W. Kiefer, Giuseppe Di, et al.. (2016). Mast cells are not associated with systemic insulin resistance. European Journal of Clinical Investigation. 46(11). 911–919. 8 indexed citations
6.
Di, Giuseppe, Giovanni Francesco Castino, Francesca Bergomas, et al.. (2015). Tertiary Lymphoid Tissue in the Tumor Microenvironment: From Its Occurrence to Immunotherapeutic Implications. International Reviews of Immunology. 34(2). 123–133. 27 indexed citations
7.
Di, Giuseppe, Nina Cortese, Giovanni Francesco Castino, et al.. (2015). Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy. Gut. 65(10). 1710–1720. 196 indexed citations
8.
Shalapour, Shabnam, Joan Font-Burgada, Giuseppe Di, et al.. (2015). Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature. 521(7550). 94–98. 429 indexed citations breakdown →
9.
Taverna, Gianluigi, et al.. (2015). Inflammation and prostate cancer: friends or foe?. Inflammation Research. 64(5). 275–286. 52 indexed citations
10.
Cortese, Nina, Giovanni Francesco Castino, Giuseppe Di, et al.. (2015). Dual prognostic significance of tumor associated macrophages in human pancreatic adenocarcinoma treated or not with chemotherapy. Pancreatology. 15(3). S51–S51. 2 indexed citations
11.
Di, Giuseppe, Francesca Bergomas, Fabio Grizzi, et al.. (2014). Occurrence of Tertiary Lymphoid Tissue Is Associated with T-Cell Infiltration and Predicts Better Prognosis in Early-Stage Colorectal Cancers. Clinical Cancer Research. 20(8). 2147–2158. 285 indexed citations
12.
Wang, Kepeng, Min Kyoung Kim, Giuseppe Di, et al.. (2014). Interleukin-17 Receptor A Signaling in Transformed Enterocytes Promotes Early Colorectal Tumorigenesis. Immunity. 41(6). 1052–1063. 263 indexed citations
13.
Di, Giuseppe, Federica Marchesi, Maria Rosaria Galdiero, & Fabio Grizzi. (2014). Immune mediators as potential diagnostic tools for colorectal cancer: from experimental rationale to early clinical evidence. Expert Review of Molecular Diagnostics. 14(3). 387–399. 6 indexed citations
14.
Di, Giuseppe & Federica Marchesi. (2014). Tertiary lymphoid tissue. OncoImmunology. 3(5). e28850–e28850. 5 indexed citations
15.
Celesti, Giuseppe, Giuseppe Di, Paolo Bianchi, et al.. (2013). Presence of Twist1-Positive Neoplastic Cells in the Stroma of Chromosome-Unstable Colorectal Tumors. Gastroenterology. 145(3). 647–657.e15. 48 indexed citations
16.
Grizzi, Fabio, Giuseppe Di, Luigi Laghi, et al.. (2013). Mast cells and the liver aging process. Immunity & Ageing. 10(1). 9–9. 24 indexed citations
17.
Di, Giuseppe, Federica Marchesi, Luigi Laghi, & Fabio Grizzi. (2013). Immune cells: plastic players along colorectal cancer progression. Journal of Cellular and Molecular Medicine. 17(9). 1088–1095. 57 indexed citations
18.
Di, Giuseppe, Giuseppe Celesti, Fabio Grizzi, et al.. (2013). Combined low-FOXP3+ and -CD3+tumor infiltrating lymphocytes: a signature of stage II MSS colorectal cancer at high-risk of recurrence. Journal for ImmunoTherapy of Cancer. 1(S1). 1 indexed citations
19.
Laghi, Luigi, Paolo Bianchi, Gabriele Delconte, et al.. (2012). MSH3 Protein Expression and Nodal Status in MLH1-Deficient Colorectal Cancers. Clinical Cancer Research. 18(11). 3142–3153. 20 indexed citations
20.
Laghi, Luigi, Stefania Beghelli, Antonino Spinelli, et al.. (2012). Irrelevance of Microsatellite Instability in the Epidemiology of Sporadic Pancreatic Ductal Adenocarcinoma. PLoS ONE. 7(9). e46002–e46002. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026